Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
August 6, 2025 Off

Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform

By GlobeNewswire

HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) — Respiree, a health tech company developing artificial intelligence (AI) platforms to…

August 5, 2025 Off

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

By GlobeNewswire

BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…

August 5, 2025 Off

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

By GlobeNewswire

         – Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis – KUALA LUMPUR, Malaysia, Aug.…

August 5, 2025 Off

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

By GlobeNewswire

DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO),…

August 5, 2025 Off

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

By GlobeNewswire

MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and…

August 5, 2025 Off

Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)

By GlobeNewswire

LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) — Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a…

August 5, 2025 Off

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

By GlobeNewswire

Cellectis to host an Investor R&D Day in New York City on October 16, 2025: Phase 1 dataset and late-stage…

August 5, 2025 Off

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

By GlobeNewswire

HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the…

August 5, 2025 Off

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

By GlobeNewswire

-CASGEVY® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 patients have had cells…

August 5, 2025 Off

Ardelyx Announces Changes to the Executive Leadership Team

By GlobeNewswire

Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial…

Posts pagination

Previous 1 … 110 111 112 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine